Cover Image
Market Research Report

Genitourinary Therapeutics Market, By Indication, By Products, And Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

Published by AnalystView Market Insights Product code 737940
Published Content info 98 Pages
Delivery time: 2-3 business days
Price
Back to Top
Genitourinary Therapeutics Market, By Indication, By Products, And Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
Published: July 22, 2017 Content info: 98 Pages
Description

REPORT HIGHLIGHT

The genitourinary therapeutics Market is estimated to represent a global market of USD 30.2 billion by 2025 with growth rate of 1.2%.

MARKET DYNAMICS

The market covers the analysis of the commercial or pipeline therapeutics that can be used for genital and urinary organ treatment. Conditions such as Glomerulonephritis, Hemolytic uremic syndrome, Polycystic kidney disease and Hydronephrosis may damage kidney. Thus, it is advisable to treat these conditions at right time. Growing demand for genitourinary therapeutics in developed as well as developing regions drives the market growth. Emerging and leading genitourinary therapeutics are studies under the scope of this research study. Furthermore, undergoing clinical trials and patents are studies during the market estimation.Constant increase in number of pipeline therapeutics in this market segment boost the market growth to large level.

For example, in September 2016, Bristol-Myers Squibb collaborated with Nektar Therapeutics to assess the efficacy of NKTR-214 and Opdivo (nivolumab) in bladder cancer. Additionally, during the same time period, the company announced the validation of the Type II variation application for Opdivo (nivolumab) in the treatment of advanced bladder cancer by the European Medicines Agency.

Indication Takeaway

The global market is categorized in terms of different indications like prostate cancer, benign prostatic hyperplasia, ovarian cancer, cervical cancer, renal cancer, erectile dysfunction, Urinary incontinence & overactive bladder, sexually transmitted diseases and others. In terms of revenue estimation, prostate and renal cancer was the market leading player as of 2016. Among which, renal cancer captured almost 26.11% share of the global revenue in 2016 whereas prostate cancer accounted for more than 20% share. Rising disease incidence in these segments coupled with continuous increase in therapeutic demand among patients drives the market growth in forecast period.

PRODUCTS TAKEAWAY

Based on products, the market studied in terms of anti-infective, urological, hormonal therapy drugs, and others. Hormonal therapy and urological segment is widely accepted products among the end user due to its high efficiency and cost effectiveness. Thereby, these segment captured largest revenue share, more than USD 12.0 billion of the global market.

Regional Takeaway

Regionally, North American countries dominated the global market with the share of over 40% throughout the study period. Research and development initiatives by domiciled key players coupled with rising prevalence of genital and urinary diseases augment the overall revenue growth. Hormonal therapy drugs such as Casodex(Bicalutamide), Lupron(Leuprolide), Zoladex(Goserelin), Zytiga(Abiraterone), Xtandi(Enzalutamide), Eligard(Leuprolide) and Gonax(degaralix) widely used in these regions which helps the market to grow steadily.

On contrary, Asia Pacific region recorded highest CAGR of 6.2% during the forecast period. Increasing awareness level coupled with improving healthcare infrastructure supported the growth in Asia and Pacific countries like India, China and Japan. Also, increasing gynaecological diseases in developing regions will further boost the demand for drugs such as Doxil(Doxorubicin), Avycaz, Estrace and Estring, further support the market growth.

The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.

The years considered for the study are:

Historical Year - 2014 & 2015

Base Year - 2015

Estimated Year - 2016

Projected Year - 2025

TARGET AUDIENCE

Hospitals

Manufacturers

Traders, Distributors, And Suppliers

Government and Regional Agencies and Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY INDICATION

Prostate cancer

Benign prostatic hyperplasia

Ovarian cancer

Cervical cancer

Renal cancer

Erectile dysfunction

Urinary incontinence & overactive bladder

Sexually transmitted diseases

Others

MARKET, BY PRODUCTS

Anti-infective

Urological

Hormonal therapy drugs

Others

MARKET, BY REGION

North America

Europe

Asia Pacific

Rest of the World

MARKET,BY COUNTRY

Further Breakdown of The North America Market

U.S.

Canada

Further Breakdown of The Europe Market

Germany

France

Rest of Europe

Further Breakdown of The APAC Market

India

China

Rest of APAC

Further Breakdown of The Rest of the World Market

Middle East and Africa

Latin America

Table of Contents

TABLE OF CONTENTS

GENITOURINARY THERAPEUTICS MARKET OVERVIEW

Study Scope

Base Year

Assumption and Methodology

EXECUTIVE SUMMARY

Key Market Facts

Geographical Scenario

Companies in the Market

GENITOURINARY THERAPEUTICS KEY MARKET TRENDS

Market Drivers

Impact Analysis of Market Drivers

Market Restraints

Impact Analysis of Market Restraints

Market Opportunities

Market Future Trends

GENITOURINARY THERAPEUTICS INDUSTRY STUDY

Company Activity Analysis

Regulatory Framework Analysis

Value Chain Analysis

GENITOURINARY THERAPEUTICS MARKET LANDSCAPE

Market Share Analysis

Key Innovators

GENITOURINARY THERAPEUTICS MARKET - BY INDICATION:

Overview

Prostate cancer

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Benign prostatic hyperplasia

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Ovarian cancer

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Cervical cancer

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Renal cancer

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Erectile dysfunction

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Urinary incontinence

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Overactive bladder

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Sexually transmitted diseases

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Others

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

GENITOURINARY THERAPEUTICS MARKET - BY PRODUCTS:

Overview

Anti-infective

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Urological

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Hormonal therapy drugs

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Others

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

GENITOURINARY THERAPEUTICS MARKET- BY GEOGRAPHY

Introduction

North America

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

S.

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Canada

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Europe

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

France

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Germany

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Rest of Europe

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Asia Pacific (APAC)

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

China

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

India

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Rest of APAC

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Rest of the World

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Latin America

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Middle East and Africa

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

KEY VENDOR ANALYSIS

GlaxoSmithKline

Company Overview

SWOT Analysis

Key Developments

Bayer AG

Company Overview

SWOT Analysis

Key Developments

Pfizer, Inc.

Company Overview

SWOT Analysis

Key Developments

Roche

Company Overview

SWOT Analysis

Key Developments

Abbott

Company Overview

SWOT Analysis

Key Developments

Novartis AG

Company Overview

SWOT Analysis

Key Developments

Bristol-Myers Squibb Company

Company Overview

SWOT Analysis

Key Developments

Antares Pharma

Company Overview

SWOT Analysis

Key Developments

360 DEGREE ANALYSTVIEW

APPENDIX

Research Methodology

Abbreviations

Disclaimer

Contact Us

SCOPE AND OBJECTIVES

The objective of this report is to describe the market trends and revenue forecasts for the GENITOURINARY THERAPEUTICS Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the genitourinary drugs Market by its major segments, which include the type, end user industry, and the major geographic regions.

KEY BENEFITS OF THE REPORT:

Understanding of the strategies that are being adopted by the key players in this market to stay competitive

Extensive analysis of the key players dominating the competitive landscape of this market

In-depth analysis of the key factors are propelling the growth of the global market

Detailed analysis of the geographic region that will witness the strongest growth

Granular analysis of the current market scenario and the expected market grow

Back to Top